These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 6110430)
1. [Catecholaminergic neuronal pathways in homeostatic control of blood circulating mass]. Zamboni P; Daniele E Boll Soc Ital Biol Sper; 1980 Dec; 56(24):2575-81. PubMed ID: 6110430 [TBL] [Abstract][Full Text] [Related]
2. [Effects of levodopa and piribedil on cyclic AMP levels in cerebrospinal fluid in rats (author's transl)]. Cramer H; Kiessling M Arzneimittelforschung; 1976; 26(6):1106-7. PubMed ID: 183794 [TBL] [Abstract][Full Text] [Related]
3. The effect of L-dopa on peripheral sympathetic nerve function: role of presynaptic dopamine receptors. Lokhandwala MF; Buckley JP J Pharmacol Exp Ther; 1978 Feb; 204(2):362-71. PubMed ID: 621670 [No Abstract] [Full Text] [Related]
4. Involvement of renal dopamine synthesis in the diuretic effect of furosemide in normohydrated rats. Nowicki S; Levin G; Enero MA J Pharmacol Exp Ther; 1993 Mar; 264(3):1377-80. PubMed ID: 8450472 [TBL] [Abstract][Full Text] [Related]
5. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A. Wiśniewska RJ Pol J Pharmacol; 1998; 50(3):203-12. PubMed ID: 9861628 [TBL] [Abstract][Full Text] [Related]
6. Proceedings: The mechanism of the effect of dopamine-beta-hydroxylase inhibitor FLA-63 on the L-DOPA reversal of reserpine akinesia. Dolphin A; Jenner P; Marsden CD Br J Pharmacol; 1975 Jun; 54(2):246P-247P. PubMed ID: 1148534 [No Abstract] [Full Text] [Related]
7. alpha-Methyldopa produces mydriasis in the rat by stimulation of CNS alpha 2-adrenoceptors. Hey JA; Ito T; Koss MC Br J Pharmacol; 1988 Jul; 94(3):834-8. PubMed ID: 2902894 [TBL] [Abstract][Full Text] [Related]
8. Effect of catecholamines on IL-2 production and NK cytotoxicity of rats in vitro. Peng YP; Qiu YH; Jiang JL; Wang JJ Acta Pharmacol Sin; 2004 Oct; 25(10):1354-60. PubMed ID: 15456539 [TBL] [Abstract][Full Text] [Related]
10. [Role of adrenergic receptors in the mechanism of action of catecholamines and DOPA on proliferative processes]. Sukmanskiĭ OI; Arkhipenko VI; Cherkashina LP Biull Eksp Biol Med; 1984 Jul; 98(7):89-91. PubMed ID: 6147165 [TBL] [Abstract][Full Text] [Related]
11. Influence of methyldopa and bromocriptine on negative pressure breathing-induced diuresis. Montastruc P; Montastruc JL; Gaillard-Plaza G J Pharmacol; 1984; 15(4):415-20. PubMed ID: 6527543 [TBL] [Abstract][Full Text] [Related]
12. [Effect of catecholamines on thirst and diuresis in the rat]. Zamboni P; Siro-Brigiani G Boll Soc Ital Biol Sper; 1966 Nov; 42(22):1657-9. PubMed ID: 5982436 [No Abstract] [Full Text] [Related]
13. Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease. Henry B; Crossman AR; Brotchie JM Exp Neurol; 1998 Jun; 151(2):334-42. PubMed ID: 9628768 [TBL] [Abstract][Full Text] [Related]
14. Dapiprazole, a selective alpha-1 adrenoceptor antagonist, inhibits diuresis but not polydipsia produced by amphetamine in rats. Nencini P; Valeri P; Morrone LA Brain Res Bull; 1990 Nov; 25(5):765-7. PubMed ID: 1981172 [TBL] [Abstract][Full Text] [Related]
15. Catecholaminergic activation of G-protein coupling in rat spinal cord: further evidence for the existence of dopamine and noradrenaline receptors in spinal grey and white matter. Venugopalan VV; Ghali Z; Sénécal J; Reader TA; Descarries L Brain Res; 2006 Jan; 1070(1):90-100. PubMed ID: 16423330 [TBL] [Abstract][Full Text] [Related]
16. Fipamezole (JP-1730) is a potent alpha2 adrenergic receptor antagonist that reduces levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease. Savola JM; Hill M; Engstrom M; Merivuori H; Wurster S; McGuire SG; Fox SH; Crossman AR; Brotchie JM Mov Disord; 2003 Aug; 18(8):872-83. PubMed ID: 12889076 [TBL] [Abstract][Full Text] [Related]
17. [Anti-thirst action of propranolol]. Zamboni P; Persichella M; Siro-Brigiani G; De Luca A Boll Soc Ital Biol Sper; 1984 Jul; 60(7):1377-9. PubMed ID: 6477750 [TBL] [Abstract][Full Text] [Related]
18. Changes in catecholaminergic pathways innervating paraventricular nucleus and pituitary-adrenal axis response during morphine dependence: implication of alpha(1)- and alpha(2)-adrenoceptors. Laorden ML; Fuertes G; González-Cuello A; Milanés MV J Pharmacol Exp Ther; 2000 May; 293(2):578-84. PubMed ID: 10773031 [TBL] [Abstract][Full Text] [Related]
19. The involvement of the catecholaminergic system in physostigmine-induced hyperactivity in rats. Egbe PC Arzneimittelforschung; 1982; 32(1):27-9. PubMed ID: 6460507 [TBL] [Abstract][Full Text] [Related]
20. Expression of tyrosine hydroxylase in the striatum of atipamezole-treated rats. Lehtonen S; Männistö PT; Raasmaja A Eur J Pharm Sci; 2009 Mar; 36(4-5):602-4. PubMed ID: 19159682 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]